Met Life Investment Management, LLC Exact Sciences Corp Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 6,475 shares of EXAS stock, worth $384,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,475
Previous 6,608 2.01%
Holding current value
$384,615
Previous $279,000 57.71%
% of portfolio
0.0%
Previous 0.0%

Shares

46 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$42.43 - $70.83 $5,643 - $9,420
-133 Reduced 2.01%
6,475 $440,000
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $23,392 - $42,031
566 Added 9.37%
6,608 $279,000
Q1 2024

May 14, 2024
BUY
$56.27 - $73.77 $339,983 - $445,718
6,042 New
6,042 $417,000
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $5,610 - $7,193
-95 Reduced 1.55%
6,025 $445,000
Q3 2023

May 09, 2024
BUY
$65.94 - $99.04 $81,633 - $122,611
1,238 Added 25.36%
6,120 $417,000
Q3 2023

Apr 29, 2024
BUY
$65.94 - $99.04 $329 - $495
5 Added 0.08%
6,120 $417,000
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $329 - $495
5 Added 0.08%
6,120 $417,000
Q2 2023

Apr 29, 2024
BUY
$62.68 - $95.05 $383,288 - $581,230
6,115 New
6,115 $574,000
Q2 2023

Aug 10, 2023
BUY
$62.68 - $95.05 $77,284 - $117,196
1,233 Added 25.26%
6,115 $574,000
Q1 2023

May 09, 2024
BUY
$47.19 - $70.77 $230,381 - $345,499
4,882 New
4,882 $331 Million
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $519 - $778
11 Added 0.23%
4,882 $331,000
Q4 2022

May 10, 2024
SELL
$30.35 - $53.15 $1,092 - $1,913
-36 Reduced 0.73%
4,871 $241,000
Q4 2022

Jun 14, 2023
SELL
$30.35 - $53.15 $333 - $584
-11 Reduced 0.23%
4,871 $241,000
Q4 2022

Mar 22, 2023
SELL
$30.35 - $53.15 $1,092 - $1,913
-36 Reduced 0.73%
4,871 $241,000
Q4 2022

Feb 15, 2023
SELL
$30.35 - $53.15 $1,092 - $1,913
-36 Reduced 0.73%
4,871 $241,000
Q3 2022

May 10, 2024
SELL
$31.97 - $49.37 $2,237 - $3,455
-70 Reduced 1.41%
4,907 $159,000
Q3 2022

Jun 14, 2023
BUY
$31.97 - $49.37 $799 - $1,234
25 Added 0.51%
4,907 $159,000
Q3 2022

Mar 22, 2023
SELL
$31.97 - $49.37 $2,237 - $3,455
-70 Reduced 1.41%
4,907 $159,000
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $2,237 - $3,455
-70 Reduced 1.41%
4,907 $159,000
Q2 2022

May 10, 2024
SELL
$35.61 - $76.23 $200,448 - $429,098
-5,629 Reduced 53.07%
4,977 $196,000
Q2 2022

Jun 20, 2023
BUY
$35.61 - $76.23 $3,382 - $7,241
95 Added 1.95%
4,977 $196,000
Q2 2022

Mar 22, 2023
SELL
$35.61 - $76.23 $200,448 - $429,098
-5,629 Reduced 53.07%
4,977 $196,000
Q2 2022

Aug 11, 2022
SELL
$35.61 - $76.23 $200,448 - $429,098
-5,629 Reduced 53.07%
4,977 $196,000
Q1 2022

May 10, 2024
BUY
$57.56 - $82.54 $610,481 - $875,419
10,606 New
10,606 $741,000
Q1 2022

Jun 20, 2023
BUY
$57.56 - $82.54 $329,473 - $472,458
5,724 Added 117.25%
10,606 $741,000
Q1 2022

Mar 22, 2023
BUY
$57.56 - $82.54 $595,861 - $854,454
10,352 Added 4075.59%
10,606 $741,000
Q1 2022

May 12, 2022
BUY
$57.56 - $82.54 $610,481 - $875,419
10,606 New
10,606 $742,000
Q4 2021

Feb 15, 2022
SELL
$72.5 - $100.68 $18,415 - $25,572
-254 Closed
0 $0
Q3 2021

Mar 22, 2023
SELL
$90.24 - $124.05 $12,633 - $17,367
-140 Reduced 35.53%
254 $24,000
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $22,920 - $31,508
254 New
254 $24,000
Q2 2021

Aug 16, 2021
SELL
$93.66 - $139.27 $36,902 - $54,872
-394 Closed
0 $0
Q1 2021

Mar 22, 2023
BUY
$116.57 - $155.01 $26,811 - $35,652
230 Added 140.24%
394 $51,000
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $45,928 - $61,073
394 New
394 $52,000
Q2 2019

Aug 14, 2019
SELL
$89.51 - $118.04 $14,679 - $19,358
-164 Closed
0 $0
Q1 2019

Jul 13, 2023
SELL
$61.98 - $96.5 $292,421 - $455,287
-4,718 Reduced 96.64%
164 $14,000
Q1 2019

Mar 22, 2023
BUY
$61.98 - $96.5 $61 - $96
1 Added 0.61%
164 $14,000
Q1 2019

May 15, 2019
BUY
$61.98 - $96.5 $61 - $96
1 Added 0.61%
164 $14,000
Q4 2018

Jul 13, 2023
SELL
$56.04 - $82.66 $264,452 - $390,072
-4,719 Reduced 96.66%
163 $10,000
Q4 2018

Mar 22, 2023
SELL
$56.04 - $82.66 $112 - $165
-2 Reduced 1.21%
163 $10,000
Q4 2018

Feb 14, 2019
SELL
$56.04 - $82.66 $112 - $165
-2 Reduced 1.21%
163 $10,000
Q3 2018

Jul 13, 2023
SELL
$48.29 - $80.6 $227,783 - $380,190
-4,717 Reduced 96.62%
165 $13,000
Q3 2018

Mar 22, 2023
SELL
$48.29 - $80.6 $227,252 - $379,303
-4,706 Reduced 96.61%
165 $13,000
Q3 2018

Nov 14, 2018
BUY
$48.29 - $80.6 $7,967 - $13,298
165 New
165 $13,000
Q2 2018

Aug 15, 2018
SELL
$37.84 - $69.96 $1.98 Million - $3.66 Million
-52,309 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$39.82 - $57.53 $80,555 - $116,383
-2,023 Reduced 3.72%
52,309 $2.11 Million
Q4 2017

Feb 15, 2018
BUY
$46.49 - $60.51 $2.53 Million - $3.29 Million
54,332
54,332 $2.86 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email